Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Recurrence 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Azacitidine 15Cyclophosphamide 13fludarabine phosphate 9Mycophenolic Acid 9Methotrexate 8Antilymphocyte Serum 8venetoclax 7Tacrolimus 7Cyclosporine 7Busulfan 7Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Radiotherapy 5Filgrastim 5Decitabine 5Cord Blood Stem Cell Transplantation 5Rituximab 4Arsenic Trioxide 4Sunitinib 3Sorafenib 3Methylprednisolone 3Melphalan 3Leucovorin 3Clofarabine 3ruxolitinib 2ponatinib 2idelalisib 2Sirolimus 2Moxifloxacin 2Injections 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myelomonocytic, Chronic × tapotoclax × Clear all
NCT05209152 2025-07-14

AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia

Amgen

Phase 1 Terminated
7 enrolled 16 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡